Jan Boegeholz, MD¹, Cedric Rossi, MD, PhD^2,3, Jordan S Goldstein, MD, MSc⁴, Stefan K. Alig, MD³, Andrea Garofalo, BS, BA⁵, Mohammad Shahrokh Esfahani, PhD^6*, Joseph G. Schroers-Martin, MD⁷, Chih Long Liu, PhD^5*, Mari Olsen, BS^5*, Xiaoman Kang, BS^8*, Feng Tian, PhD^5*, David Kurtz, MD, PhD^9,10, Marc Andre, MD^11*, Luc-Matthieu Fornecker, MD, PhD^12*, Olivier Casasnovas, MD^13*, Maximilian Diehn, MD, PhD^6*, Herve Ghesquieres, MD, PhD^14* and Ash A. Alizadeh, MD, PhD⁵

¹Divisions of Hematology and Oncology, Stanford University, Stanford, CA
²CHU Dijon, DIJON, France
³Stanford University, Stanford, CA
⁴Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Palo Alto, CA
⁵Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁶Department of Radiation Oncology, Stanford University, Stanford, CA
⁷Department of Medicine, Division of Oncology and Hematology, Stanford University, Menlo Park, CA
⁸Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
⁹Department of Medicine (Oncology), Stanford University, Palo Alto, CA
¹⁰Foresight Diagnostics, Boulder, CO
¹¹CHU UCL Namur Mont-Godinne, Yvoir, Belgium
¹²Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
¹³François Mitterand Hospital, Dijon, FRA
¹⁴Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France

Justin Ferdinandus, MD^1,2*, Helen Kaul, Dipl.-Math.^3,4*, Gundolf Schneider, MSc^1,4*, Michael Fuchs, MD^1,4*, Hans Theodor Eich, MD^1,5*, Christian Baues, MD^1,6*, Johannes Rosenbrock, MD^1,7*, Katrin S Roth, MD^8*, Alexander Drzezga^8*, Lutz Van Heek^8*, Markus Dietlein^1,8*, Peter Borchmann, MD^1,2 and Carsten Kobe, MD^1,8*

¹German Hodgkin Study Group, Cologne, Germany
²University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Cologne, Germany
³German Hodgkin Study Group (GHSG), Cologne, Germany
⁴Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
⁵Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany
⁶Department of Radiation Oncology, University Hospital of Ruhr-Universität Bochum, Marien Hospital Herne, Herne, Germany
⁷Department of Radiation Oncology and Cyberknife Center, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
⁸Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany

Angie Mae Rodday, PhD¹, Susan K. Parsons, MD, MRP², Zhu J Cui, MD, MPH^3*, Qingyan Xiang, PhD^1*, Nicholas Counsell^4*, Sara Rossetti, MD^5*, Jenica N Upshaw, MD^6*, Annalynn M Williams, PhD⁷, Amy A Kirkwood, MSc^8*, Hongli Li, MS^9*, James R. Cerhan, MD, PhD¹⁰, Massimo Federico, MD¹¹, Jonathan W. Friedberg, MD¹², Andrea Gallamini, MD^13*, Eliza A. Hawkes, MD¹⁴, David Hodgson, MD^15*, Martin Hutchings, MD, PhD¹⁶, Peter Johnson^17*, Brian K. Link, MD^18*, Eric Mou, MD^18*, John Radford^19*, Kerry J. Savage, MD, MSc²⁰, Deborah M. Stephens, DO²¹, Pier Luigi Zinzani, MD²², Matthew J. Maurer, DSc²³ and Andrew M Evens, DO MBA MSc²⁴

¹Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
²Division of Hematology and Oncology and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
³Tufts Medical Center, Boston
⁴University College London, Cancer Trials Centre, London, United Kingdom
⁵Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
⁶Cardio-Oncology Program, Tufts Medical Center, Boston, MA
⁷University of Rochester, Rochester, NY
⁸Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom
⁹Fred Hutchinson Cancer Center, Seattle, WA
¹⁰Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹¹University of Modena and Reggio Emilia, Modena, MO, ITA
¹²Wilmot Cancer Center, University of Rochester, Rochester, NY
¹³Antoine Lacassagne Cancer Centre, Nice, Paca, ITA
¹⁴Austin Health, Olivia Newton John Cancer Research Institute, Heidelberg, VIC, Australia
¹⁵Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁶Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
¹⁷School of Cancer Sciences, University of Southampton, Southampton, United Kingdom
¹⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹⁹The Christie NHS Foundation Trust, Manchester, United Kingdom
²⁰Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
²¹University of North Carolina Chapel Hill, Chapel Hill, NC
²²University of Bologna, Istituto Di Ematologia, Bologna, Italy
²³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
²⁴Rutgers Cancer Institute, New Brunswick, NJ

Justin Ferdinandus, MD^1,2*, Helen Kaul, Dipl.-Math.^3,4*, Alexander Fosså, MD, PhD^5*, Andreas Hüttmann, MD^6*, Felix Keil, MD^7,8*, Yon-Dschun Ko, MD^9*, Felicitas Hitz^10,11*, Michaela Schwarz^12*, Corinna Trenker, MD^13*, Andrea Kerkhoff, MD^14*, Peter Staib^15*, Kai Wille, MD^16*, Irmgard Dresel^17*, Dennis Hahn^18*, Bernd Hertenstein, MD^19*, Peter Moosmann^11,20*, Ulrich Mey, MD, Prof.^11,21, Stefan Balabanov, MD, PhD^11,22*, Tasman Armytage, MBBS, BSc, FRACP, FRCPA^23,24*, Fernando Roncolato^25,26*, Johannes Christian Hellmuth, MD^27*, Stefanie Kreissl^28*, Michael Fuchs, MD^1,3*, Gundolf Schneider, MSc^1,3*, Hishan Tharmaseelan, MD^1,29*, Dennis A Eichenauer, MD^1,3*, Bastian von Tresckow^1,30, Peter Borchmann, MD^1,31 and Paul J. Bröckelmann, MD^1,31*

¹German Hodgkin Study Group, Cologne, Germany
²University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Cologne, Germany
³Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany
⁴German Hodgkin Study Group (GHSG), Cologne, Germany
⁵Department of Oncology, Oslo University Hospital, Oslo, Norway
⁶Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, NRW, DEU
⁷Department of Haematology, Hanusch Krankenhaus, Wien, AUT
⁸Austrian Group of Medical Tumor Therapy (AGMT) Study Group, Vienna, Austria
⁹Department of Internal Medicine, Johanniter Hospital, Bonn, Germany
¹⁰Department of Medical Oncology/Hematology, Kantonsspital St.Gallen, Winterthur, CHE
¹¹Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
¹²Department of Hematology, Campus Virchow Clinic, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Berlin, DEU
¹³Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, DEU
¹⁴Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹⁵Department of Hematology and Oncology, St Antonius Hospital Eschweiler, Eschweiler, DEU
¹⁶University of Bochum, University Clinic For Hematology and Oncology Minden, Bochum, Germany
¹⁷Department of Hematology, Ortenau Klinikum, Offenburg, Germany
¹⁸Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
¹⁹Department of Internal Medicine I, Klinikum Bremen Mitte, Bremen, Germany
²⁰Cantonal Hospital Aarau, Zurich, Zurich, CHE
²¹Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland
²²Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
²³Gosford Hospital, Gosford, Australia
²⁴Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
²⁵The Australasian Leukaemia & Lymphoma Group (ALLG), Melbourne, Australia
²⁶St George Hospital, Kogarah, Australia
²⁷Department of Medicine III, LMU Munich, Munich, Germany
²⁸Hospital Ordensklinikum Linz, Linz, Austria
²⁹Faculty of Medicine, University of Cologne, Cologne, Germany, Cologne, Germany
³⁰Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
³¹University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany

Alison Moskowitz, MD¹, Gunjan L. Shah, MD², Nivetha Ganesan, MPH^3*, Tiffany Chang, MS^3*, Esther Drill, DrPH^3*, Theresa Davey, MMSc, PA-C^3*, Helen Hancock, ANP^3*, Brittney Munayirji^3*, Monifa Douglas^3*, Alayna M. Santarosa, MPH^3*, Ellie Casper, MS, DPT^1*, Natasha Galasso^3*, Sarima Subzwari^3*, Marwah Jihad^4*, Alexander P. Boardman, MD^1*, Philip Caron, MD¹, Kevin A. David, MD^1*, Zachary D. Epstein-Peterson, MD¹, Lorenzo Falchi, MD³, Paola Ghione, MD, MSEpi³, Paul A. Hamlin, MD¹, Steven Horwitz, MD¹, Andrew M. Intlekofer, MD, PhD¹, William T. Johnson, DO⁵, Anita Kumar, MD⁶, Jennifer Kimberly Lue, MD¹, Efrat Luttwak, MD¹, Ariela Noy, MD¹, Colette Owens, MD¹, Maria Lia Palomba, MD¹, Gilles Salles, MD, PhD⁷, Raphael Steiner, MD^1*, Robert Stuver, MD¹, Pallawi Torka, MD¹, Santosha A. Vardhana, MD, PhD⁸, Andrew D. Zelenetz, MD, PhD¹, Joachim Yahalom, MD⁹, Ahmet Dogan, MD, PhD³, Heiko Schoder, MD^3* and Craig H. Moskowitz, MD¹⁰

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, NEW YORK, NY
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
⁷Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL

Sanjal H. Desai, MBBS^1,2, Michael A Spinner, MD³, Alice Sykorova^4*, Veronika Bachanova, MD, PhD⁵, Andrew M Evens, DO MBA MSc⁶, Gaurav Goyal, MD⁷, Brad S. Kahl, MD⁸, Kathleen Dorritie, MD⁹, Jacques Azzi¹⁰, Vaishalee P Kenkre, MD¹¹, Cheryl Chang, BA^12*, Jozef Michalka, MD^13*, Stephen M. Ansell, MD, PhD¹⁴, Brendon Fusco, MD¹⁵, Nuttavut Sumransub, MD⁵, Haris Hatic, DO¹⁶, Raya Saba, MD, MS¹⁷, Uroosa Ibrahim, MD¹⁸, Elyse I Harris, MD^11*, Harsh R. Shah, DO¹⁹, Nina D. Wagner-Johnston, MD²⁰, Sally Arai, MD²¹, Grzegorz S. Nowakowski, MD², Heidi Mocikova, MD^22*, Deepa Jagadeesh, MD²³, Kristie A. Blum, MD²⁴, Catherine S. Diefenbach, MD²⁵, Siddharth Iyengar, MD^26*, K. C. Rappazzo, MD^27*, Firas Baidoun, MD²⁸, Yun Choi, MD^29*, Vit Prochazka, MD, PhD³⁰, Ranjana H. Advani, MD³¹ and Ivana N. Micallef^2*

¹Masonic Cancer Center, University of Minnesota, Minneapolis, MN
²Mayo Clinic, Rochester, MN
³Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
⁴4th Department of Internal Medicine– Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, CZE
⁵Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
⁶Rutgers Cancer Institute, New Brunswick, NJ
⁷University of Birmingham Alabama, Birmingham, AL
⁸Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁹UPMC Hillman Cancer Center, Pittsburgh, PA
¹⁰Division of Hematology & Medical Oncology, Cellular Therapy and Bone Marrow Transplant, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹¹Carbone Cancer Center, University of Wisconsin–Madison, Madison, WI
¹²Duke University School of Medicine, Durham, NC
¹³Hematology, Faculty of Medicine Masaryk University and University Hospital Brno, Brno, Czech Republic
¹⁴Division of Hematology, Mayo Clinic, Rochester, MN
¹⁵Department of Hematology & Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹⁶Suburban Hematology-Oncology Associates-Lawrenceville, Lawrenceville, GA
¹⁷Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Kansas City, MO
¹⁸Division of Hematology & Medical Oncology, Cellular Therapy and Bone Marrow Transplant, Tisch Cancer Institute/ Icahn School of Medicine at Mount Sinai, New York, NY
¹⁹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁰Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
²¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
²²Department of Internal Medicine – Hematology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE
²³Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²⁴Winship Cancer Institute of Emory University, Atlanta, GA
²⁵Perlmutter Cancer Center at NYU Langone Health, New York, NY
²⁶Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁷Division of Hematology, Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
²⁸Cleveland Clinic Taussig Cancer Center, Cleveland, OH
²⁹Perlmutter Cancer Center At NYU Langone Health, NYU Grossman School of Medicine, New York, NY
³⁰Head of the Lymphoma Research Group, Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Olomouc, Czech Republic
³¹Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA